In certain eye diseases, cells that are crucial for vision die off, with no innate way to rebuild their supply. But scientists around the world are increasingly deploying treatments derived from stem cells, placing them in patients’ eyes in hopes of regenerating the lost tissue.

Two research groups in the past two months have reported enticing results from approaches using embryonic stem cells, finding that their therapies appear to be safe and even produced some vision gains.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy